Brief: Abcellera's Microfluidic Cell Culture Patent Affirmed Valid By U.S. Court Of Appeals For Federal Circuit
May 12 (Reuters) - Abcellera Biologics Inc ABCL.O: ABCELLERA’S MICROFLUIDIC CELL CULTURE PATENT AFFIRMED VALID BY THE U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT Source text: ID:nBw4m8L09a Further company coverage: ABCL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AbCellera Biologics
See all newsAbCellera Biologics Inc. reports results for the quarter ended September 30 - Earnings Summary
Canada's AbCellera Q3 revenue beats analyst estimates
Factbox: Pharma sector doubles down on AI to slash costs, timelines
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce